查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598450

组织银行市场：按产品、应用程式和最终用户划分 - 全球预测 2025-2030 年

Tissue Banking Market by Product (Consumables, Equipment), Application (Cosmetics, Medical research, Therapeutics), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年机构银行市场估值为338.1亿美元，预计2024年将达到371.3亿美元，复合年增长率为9.91%，到2030年将达到655.4亿美元。

范围和定义包括出于治疗和研究目的而收集、处理、储存和分配人体组织。这个过程对于再生医学、癌症治疗和移植等应用至关重要，并且是生物医学研究的重要资源。组织库在确保及时获取符合品质和安全标准的组织方面发挥关键作用。最终用途范围包括医院、研究机构和生物製药公司，每个公司都将组织用于特定用途，从直接患者治疗到高级医学研究和新治疗方法的开发。

主要市场统计
基准年[2023] 338.1亿美元
预测年份 [2024] 371.3亿美元
预测年份 [2030] 655.4亿美元
复合年增长率（%） 9.91%

影响组织库市场的主要成长要素包括生物技术的进步、再生医学需求的增加以及需要先进治疗解决方案的慢性病盛行率的上升。政府促进组织研究的措施以及製药公司增加研发投资的措施进一步支持了这一成长。一个显着的机会在于医疗保健基础设施改善和组织输送意识提高所推动的新兴市场的扩张。为了利用这一优势，企业应专注于开发具有成本效益和高效的组织保存技术，提高组织工程产品的可靠性，并与学术和研究机构形成策略联盟。

影响市场成长的挑战包括管理组织银行业务的严格法律规范以及有关组织提供和使用的道德问题。组织保存和长期保存的技术障碍也构成了重大挑战。低温保存方法的创新、组织处理的自动化以及用于资料管理的生物银行软体的开发为研究和业务成长提供了有前景的领域。

这个市场的特点是监管和道德考虑以及快速技术进步之间复杂的相互作用。因此，企业在投资尖端研发的同时必须优先考虑遵守监管标准。与监管机构合作、培训投资以及有关纸巾产品的公众意识宣传活动是促进市场扩张和解决当前限制的推荐策略。

市场动态：揭示快速发展的机构银行市场的关键市场洞察

供给和需求的动态交互作用正在改变机构银行市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球生物样本库的兴起
    • 政府努力改善医疗机构的医疗设施
    • 移植医学的快速发展和人体组织的使用不断增加
  • 市场限制因素
    • 在受控环境中保存活组织的高成本
  • 市场机会
    • 由于药物分析的重大进步，组织保存变得更加复杂
    • 医疗保健领域生物样本库技术的进步
  • 市场挑战
    • 组织银行业务的局限性

波特五力：驾驭机构银行市场的策略工具

波特的五力架构是了解组织银行市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解机构银行市场的外部影响

外部宏观环境因素在塑造机构银行市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解组织银行市场的竞争状况

对组织银行市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 组织银行市场供应商的定位矩阵绩效评估

FPNV 定位矩阵是评估机构银行市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划组织银行市场的成功之路

组织银行市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 生物样本库在世界各地不断兴起
      • 政府努力改善医疗机构的医疗设施
      • 移植医学快速发展，人体组织应用不断增加
    • 抑制因素
      • 在受控环境中保存生物组织的成本很高
    • 机会
      • 药物分析的重大进展升级了组织保存
      • 医疗保健领域生物银行技术的进步
    • 任务
      • 组织银行业务的限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章组织银行市场：依产品

  • 消耗品
  • 装置

第七章 组织银行市场：依应用分类

  • 化妆品
  • 医学研究
  • 治疗药物

第八章 组织银行市场：依最终使用者分类

  • 生物样本库
  • 医院/诊所
  • 研究/学术机构

第九章美洲的组织银行市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太组织银行市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的组织银行市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • BioKryo GmbH
  • Bluechiip Limited
  • Chernobyl Tissue Bank
  • Corning Incorporated
  • Eli Lilly & Company
  • Merck KGaA
  • Organ Recovery Systems, Inc.
  • Panasonic Corporation
  • PHC Holdings Corporation
  • QIAGEN NV
  • Sanofi SA
  • Taylor-Wharton International LLC
  • Thermo Fisher Scientific Inc.
  • VIVEX Biologics, Inc.
Product Code: MRR-03142C0401D3

The Tissue Banking Market was valued at USD 33.81 billion in 2023, expected to reach USD 37.13 billion in 2024, and is projected to grow at a CAGR of 9.91%, to USD 65.54 billion by 2030.

The scope and definition of tissue banking encompass the collection, processing, storage, and distribution of human tissues for therapeutic and research purposes. This process is crucial for applications in regenerative medicine, cancer treatment, and transplantation, as well as serving as a vital resource in biomedical research. Tissue banks play an essential role in ensuring the timely availability of tissues that meet quality and safety standards. The end-use scope includes hospitals, research institutes, and biopharmaceutical companies, each utilizing the tissues for their specific applications, ranging from direct patient care to advanced medical research and the development of novel therapies.

KEY MARKET STATISTICS
Base Year [2023] USD 33.81 billion
Estimated Year [2024] USD 37.13 billion
Forecast Year [2030] USD 65.54 billion
CAGR (%) 9.91%

Key growth factors influencing the tissue banking market include advancements in biotechnology, increasing demand for regenerative medicine, and the rising prevalence of chronic diseases necessitating advanced therapeutic solutions. Government initiatives promoting tissue-based research and increasing R&D investments by pharmaceutical companies further bolster this growth. Notable opportunities lie in expanding emerging markets, underscored by improving healthcare infrastructure and growing tissue donation awareness. To capitalize, businesses should focus on developing cost-effective and efficient tissue preservation techniques, enhancing the reliability of tissue-engineered products, and forming strategic partnerships with academic and research institutions.

Challenges affecting market growth include stringent regulatory frameworks governing tissue banking operations and ethical concerns related to tissue donation and usage. Technological hurdles in the preservation and long-term storage of tissues also pose significant challenges. Innovations in cryopreservation methods, automation in tissue processing, and development of bio-banking software for data management present promising areas for research and business growth.

The market is characterized by a complex interplay of regulatory and ethical considerations, mixed with rapid technological advancements. Thus, companies must prioritize compliance with regulatory standards while investing in cutting-edge research and development. Collaboration with regulatory bodies, investment in training, and public awareness campaigns about tissue donation are recommended strategies to foster market expansion and address current limitations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Banking Market

The Tissue Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of bio banks across the globe
    • Government initiatives by healthcare organizations to improvise healthcare facilities
    • Rapid development of transplant medicine and rise in applications of human tissue
  • Market Restraints
    • High-cost involved in preservation of biological tissues under controlled environments
  • Market Opportunities
    • Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
    • Advancements in biobanking technology in the healthcare sector
  • Market Challenges
    • Limitations of tissue banking

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Banking Market

A detailed market share analysis in the Tissue Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Banking Market

A strategic analysis of the Tissue Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Banking Market, highlighting leading vendors and their innovative profiles. These include Beckman Coulter, Inc., Bio-Rad Laboratories Inc., BioKryo GmbH, Bluechiip Limited, Chernobyl Tissue Bank, Corning Incorporated, Eli Lilly & Company, Merck KGaA, Organ Recovery Systems, Inc., Panasonic Corporation, PHC Holdings Corporation, QIAGEN N.V., Sanofi SA, Taylor-Wharton International LLC, Thermo Fisher Scientific Inc., and VIVEX Biologics, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Equipment.
  • Based on Application, market is studied across Cosmetics, Medical research, and Therapeutics.
  • Based on End User, market is studied across Biobanks, Hospitals & Clinics, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of bio banks across the globe
      • 5.1.1.2. Government initiatives by healthcare organizations to improvise healthcare facilities
      • 5.1.1.3. Rapid development of transplant medicine and rise in applications of human tissue
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost involved in preservation of biological tissues under controlled environments
    • 5.1.3. Opportunities
      • 5.1.3.1. Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
      • 5.1.3.2. Advancements in biobanking technology in the healthcare sector
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations of tissue banking
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Banking Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Equipment

7. Tissue Banking Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetics
  • 7.3. Medical research
  • 7.4. Therapeutics

8. Tissue Banking Market, by End User

  • 8.1. Introduction
  • 8.2. Biobanks
  • 8.3. Hospitals & Clinics
  • 8.4. Research & Academic Institutes

9. Americas Tissue Banking Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Banking Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Banking Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Beckman Coulter, Inc.
  • 2. Bio-Rad Laboratories Inc.
  • 3. BioKryo GmbH
  • 4. Bluechiip Limited
  • 5. Chernobyl Tissue Bank
  • 6. Corning Incorporated
  • 7. Eli Lilly & Company
  • 8. Merck KGaA
  • 9. Organ Recovery Systems, Inc.
  • 10. Panasonic Corporation
  • 11. PHC Holdings Corporation
  • 12. QIAGEN N.V.
  • 13. Sanofi SA
  • 14. Taylor-Wharton International LLC
  • 15. Thermo Fisher Scientific Inc.
  • 16. VIVEX Biologics, Inc.

LIST OF FIGURES

  • FIGURE 1. TISSUE BANKING MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE BANKING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE BANKING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE BANKING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE BANKING MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE BANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE BANKING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE BANKING MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE BANKING MARKET SIZE, BY MEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE BANKING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE BANKING MARKET SIZE, BY BIOBANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE BANKING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE BANKING MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES TISSUE BANKING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA TISSUE BANKING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM TISSUE BANKING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. TISSUE BANKING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. TISSUE BANKING MARKET, FPNV POSITIONING MATRIX, 2023